Ngamcherdtrakul, W., Castro, D. J., Gu, S., Morry, J., Reda, M., Gray, J. W., & Yantasee, W. (2016). Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment. Cancer Treat Rev.
Chicago-tyylinen lähdeviittausNgamcherdtrakul, Worapol, David J. Castro, Shenda Gu, Jingga Morry, Moataz Reda, Joe W. Gray, ja Wassana Yantasee. "Current Development of Targeted Oligonucleotide-based Cancer Therapies: Perspective On HER2-positive Breast Cancer Treatment." Cancer Treat Rev 2016.
MLA-viiteNgamcherdtrakul, Worapol, et al. "Current Development of Targeted Oligonucleotide-based Cancer Therapies: Perspective On HER2-positive Breast Cancer Treatment." Cancer Treat Rev 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.